Posts by: Patricia Inacio, PhD

News

A diet rich in multiple carbohydrate sources, including sugars, starchy carbohydrates, and dietary fiber, is a likely perpetrator of inflammatory bowel disease (IBD), two researchers believe. They say the ... Read more

January 28, 2019January 28, 2019

Pseudopolyps Do Not Predict Colorectal Cancer Risk in IBD Patients, 20-year Retrospective Study Shows

News

Pseudopolyps — large protrusions of the intestinal layer formed in the regenerative and healing phases of damaged tissue — are not predictors of risk for developing colorectal cancer among patients with ... Read more

January 9, 2019January 9, 2019

Malnutrition Puts Children with Crohn’s at Higher Risk of Post-surgery Complications, Study Says

News

Worsening degrees of malnutrition are directly linked to a higher risk of 30-day complications in children with Crohn’s disease who have undergone major bowel surgery, a study says. The ... Read more

January 2, 2019January 2, 2019

Immunic Will Develop IMU-856, Promising IBD Therapy

News

Immunic earned the exclusive rights to develop a group of innovative disease-modifying therapies, now renamed IMU-856, for inflammatory bowel disease (IBD). IMU-856, originally developed by Daiichi Sankyo, is an oral ... Read more

November 28, 2018November 28, 2018

Cosentyx May Increase Risk for Inflammatory Bowel Disease, Italian Researchers Say

News

Italian researchers are calling attention to what they say is an alarming number of newly diagnosed cases of inflammatory bowel disease (IBD) in people treated with the human monoclonal ... Read more

November 16, 2018November 16, 2018

Crohn’s and Ulcerative Colitis Prevalence in Canada — Already High — Will Almost Double by 2030, Report Warns

News

Canada has the world’s highest prevalence of the two main forms of inflammatory bowel disease (IBD) — Crohn’s disease and ulcerative colitis — and the incidence of IBD is increasing ... Read more

November 2, 2018November 2, 2018

Antibiotic Use May Promote IBD Development by Disrupting Gut Immune Cells, Mouse Study Suggests

News

Antibiotics can disrupt immune cells residing in the gut, triggering the rise of pro-inflammatory cells and reducing healthy bacteria — two steps key in the development of inflammatory bowel ... Read more

September 5, 2018September 5, 2018

Investigational ABX464 Enhances Remission Rates, Mucosal Healing in Ulcerative Colitis Patients in Phase 2a Trial

News

Abivax‘s small, anti-inflammatory molecule ABX464 significantly increased clinical remission and mucosal healing over placebo in patients with moderate to severe active ulcerative colitis resistant to other therapies, top-line results from ... Read more

August 24, 2018August 24, 2018

Eating Strawberries Reduces Colon Inflammation, Improves Gut Health in IBD Mouse Model

News

Less than a cupful of whole strawberries a day led to a significant decrease in colon inflammation and reversal of the pro-inflammatory gut microbiome in a mouse model of ... Read more

August 3, 2018August 3, 2018

Pfizer’s Xeljanz Approved in EU for Adults with Moderate to Severe Ulcerative Colitis

News, Ulcerative colitis

The European Commission has approved Pfizer‘s Xeljanz (tofacitinib) for the treatment of adults with moderate to severe active ulcerative colitis (UC) who have failed to fully respond to other therapies. ... Read more

Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

‘Carbohydrate Monotony’ Diet May Ease IBD, Researchers Propose

Pseudopolyps Do Not Predict Colorectal Cancer Risk in IBD Patients, 20-year Retrospective Study Shows

Malnutrition Puts Children with Crohn’s at Higher Risk of Post-surgery Complications, Study Says

Immunic Will Develop IMU-856, Promising IBD Therapy

Cosentyx May Increase Risk for Inflammatory Bowel Disease, Italian Researchers Say

Crohn’s and Ulcerative Colitis Prevalence in Canada — Already High — Will Almost Double by 2030, Report Warns

Antibiotic Use May Promote IBD Development by Disrupting Gut Immune Cells, Mouse Study Suggests

Investigational ABX464 Enhances Remission Rates, Mucosal Healing in Ulcerative Colitis Patients in Phase 2a Trial

Eating Strawberries Reduces Colon Inflammation, Improves Gut Health in IBD Mouse Model

Pfizer’s Xeljanz Approved in EU for Adults with Moderate to Severe Ulcerative Colitis

Pin It on Pinterest